You are here

  • Home
  • Archive
  • Volume 6, Issue 4
  • Review: calcium antagonists lead to a higher risk for myocardial infarction, congestive heart failure, and major cardiovascular events

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: calcium antagonists lead to a higher risk for myocardial infarction, congestive heart failure, and major cardiovascular events

https://doi.org/10.1136/ebm.6.4.110

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2000) Lancet 356, 1949. Pahor M, Psaty BM, Alderman MH, et al.. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.. Dec 9;. :. –54..
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In patients with hypertension, are calcium antagonists (CAs) as first line treatment superior, equal, or inferior to other antihypertensive drugs for reducing major cardiovascular events?

    Data sources

    Studies were identified by searching Medline up to September 2000, the US National Library of Medicine clinical trials database, and the Cochrane Library; by reviewing reference lists of identified articles; and by contacting colleagues.

    Study selection

    Studies were selected if they were randomised controlled trials published in peer reviewed journals that included >100 patients with hypertension who were allocated to first line treatment with a CA or other antihypertensive agent and who were followed for ≥2 years for the assessment of cardiovascular events.

    Data extraction

    Data were extracted on drug type and dose, patient characteristics, and main outcomes. Summary data were pooled.

    Main results

    9 trials involving 27 743 patients with about 120 000 person years of follow up met the selection criteria. CAs and other antihypertensive agents led to similar reductions in blood pressure. Patients …

    View Full Text

    Footnotes

    • Source of funding: not stated.

    • For correspondence: Professor M Pahor, Sticht Center on Aging, Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Fax + 1 336 713 8588.